Alnylam Pharmaceuticals
ALNY
#632
Rank
C$55.62 B
Marketcap
C$416.60
Share price
-1.01%
Change (1 day)
-0.84%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend yield history for this company